⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6854652 | 0.70 | — | — | |
| Propiolic Acid SCHEMBL1077 | 0.67 | — | — | |
| SCHEMBL405887 | 0.67 | — | — | |
| Propiolic Acid SCHEMBL4192977 | 0.67 | CA1 (0.36) | — | |
| SCHEMBL529780 | 0.67 | — | — | |
| SCHEMBL497542 | 0.67 | — | — | |
| Propiolic Acid SCHEMBL1569415 | 0.64 | — | — | |
| SCHEMBL6501689 | 0.64 | — | — | |
| SCHEMBL15662481 | 0.64 | — | — | |
| Propiolic Acid SCHEMBL18047804 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245175-A1 | MACROCYCLIC HETEROAROMATIC INHIBITORS OF JAK2 | AJAX THERAPEUTICS, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| EP-4624465-A1 | COMPOUND SERVING AS DDR1 KINASE INHIBITOR, AND MEDICINE | Nippon Shinyaku Co., Ltd. (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-20240092718-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED CARBOXYLIC ACIDS AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Hemoshear Therapeutics, Inc. | 2024-03-21 | — | — | US | disclosed |
| EP-4281057-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED CARBOXYLIC ACIDS AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Hemoshear Therapeutics, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| US-20230259031-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| CN-115109060-A | Method for selectively synthesizing quinoline-2-ketone by copper-catalyzed alpha-bromocarbonyl alkyne and maleimide serial cyclization | 湖南警察学院 | 2022-09-27 | — | — | CN | disclosed |
| CN-115093368-A | Method for preparing quinoline-2, 4-diketone derivative by copper-catalyzed cyclization/oxidation cleavage of alpha-bromocarbonyl alkyne | 湖南警察学院 | 2022-09-23 | — | — | CN | disclosed |
| CN-114908127-A | Use of enzyme-TiO 2 Method for catalytic synthesis of nanotube-quantum dot co-assembly | 杭州师范大学 | 2022-08-16 | — | — | CN | disclosed |
| WO-2022159540-A1 | METHODS FOR SYNTHESIZING SUBSTITUTED CARBOXYLIC ACIDS AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Hemoshear Therapeutics, Inc. (US) | 2022-07-28 | — | — | WO | disclosed |
| CN-109952297-B | Compound (I) | 奥斯陆大学 | 2022-02-25 | — | — | CN | disclosed |
| US-6200996-B1 | ARTHRITIS; BONE, GASTROINTESTINAL DISORDERS; CROHN*S DISEASE, MULTIPLE SCLEROSIS | AMERICAN CYANAMID COMPANY | 2001-03-13 | — | — | US | disclosed |
| WO-2000044716-A1 | ACETYLENIC SULFONAMIDE THIOL TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000044709-A2 | ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000044749-A1 | ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000044711-A1 | ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000044710-A2 | ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000044740-A2 | HETEROARYL ACETYLENIC SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| US-5436361-A | Deprotonation using bases with propargyl halides | CLEMSON UNIVERSITY (US) | 1995-07-25 | — | — | US | disclosed |
| US-5208223-A | Enzyme inhibitors | AMERICAN CYANAMID COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| US-5144045-A | Treatment of inflammatory related disorders | AMERICAN CYANAMID COMPANY (US) | 1992-09-01 | — | — | US | disclosed |